Hello, everyone, and how are you today? A bright sun is enveloping the Pharmalot corporate campus this morning as we hustle about to deliver the short people to their various school houses for another round of learning. Busy, busy, busy. And so we are quickly quaffing a cup of stimulation so we can fortify ourselves for our own schedule of reading, phone calls and writing. Meanwhile, here are some tidbits. Good luck conquering the world...
Roche Moves Cancer Drugs In China By Selling Health Insurance (Bloomberg News)
Cost Becomes A Bigger Factor In Treating Heart Disease (Reuters)
German Court Voids Seroquel XR Patent (Associated Press)
Regeneron To Add 300 Jobs In New York (Albany Business Review)
Lilly Rheumatoid Arthritis Pill Is Effective In Study (Reuters)
FDA Blocks Hospira From Importing Infusion Pump (Reuters)
WADA Chief Warms Armstrong Case Is Tip Of Iceberg (Associated Press)
Compliance And Research Integrity At Princeton (The Princetonian)
Gilead May Have An Edge On Rivals In Hepatitis C (Bloomberg News)
Head Injury And Pesticides Tied To Parkinson's (Reuters)
New Zealanders Not Getting Free Meds They Should: Study (Pharma Times)
Protalix Close To Deal With Brazilian Government (Globes)
Lebanese President Vows Punishment For Illegal Importations (Now Lebanon)
EDITOR'S NOTE: Please check this post for updates
1 Comment